2019 MOTIVATE Course 2: History Taking, Diagnosing, and Treatment of MOH

2019 MOTIVATE Course 2: History Taking, Diagnosing, and Treatment of MOH

Current Status
Not Enrolled
Get Started

1 Category 2 points with the RACGP

1 Core PDP point

All participants will be awarded a certificate of completion for self-reporting to other colleges

Duration: 30 minutes

Taking a proper history plays a big part in diagnosing headache. Physical examination and laboratory testing only rarely offer diagnostic clues. Using a simulated case study, recall the process of detailed history taking to elicit a comprehensive headache history. Also. learn the different treatment modalities of MOH.

Learning objectives:
Upon completing this course, participants will be able to:

  • outline the process of detailed history taking to elicit a comprehensive headache history and be able to identify any secondary headaches that should be further investigated
  • explain the different treatment modalities of MOH
  • differentiate the pros and cons of outpatient versus inpatient withdrawal therapy
  • create a checklist to serve as reminder of the different side effects associated with prophylactic medications.
  • Associate Professor Richard Stark, Alfred Hospital, Melbourne, Victoria
  • Professor Mieke Van Driel, School of Medicine, University of Queensland, Herston, Queensland
  • Associate Professor Treasure McGuire, School of Pharmacy, University of Queensland, Queensland; Faculty of Health Sciences & Medicine, Bond University, Gold Coast, Queensland
  • Dr Brett McFarlane, The Australian College of Pharmacy, Canberra, Australian Capital Territory
  • Professor Deborah Turnbull, School of Psychology, University of Adelaide, South Australia

  • Royal Australian College of General Practitioners:
    • 1 Category Two QI&CPD points
    • Activity no. 108889
  • Australian College of Rural and Remote Medicine:
    • 1 Core PDP point
    • Activity no. 10378
  • Pharmacists and nurses are invited to access this continuing professional development activity. At the end, a certificate may be downloaded as proof of completion.

Dr Lara Mihaljevic
General Practitioner
Drummoyne Medical Centre, Victoria Road, Drummoyne, NSW

  • Faculty
    • Associate Professor Richard Stark: Co-authored a clinical paper sponsored by Pfizer on the safety of eletriptan. Between 2012 and 2014 received consulting and lecture fees from Allergan and lecture fees from MSD on chronic migraine
    • Professor Mieke Van Driel: No conflict of interest
    • Associate Professor Treasure McGuire: No conflict of interest
    • Dr Brett McFarlane: No conflict of interest
    • Professor Deborah Turnbull: Received research grants and co-authored papers on hypertension sponsored by pharmaceutical companies, including Pfizer Pty. Ltd., between 1999 and 2006
  • GP reviewer
    • Dr Lara Mihaljevic: No conflict of interest
  • Non-faculty: employees of In Vivo Academy involved in producing the content of this course, Yulyana, Tina Garcia, Monica Kurniawan and Lisa Sullivan, declare no conflict of interest.